PillHeparin Sodium And Dextrose
Dextrose Monohydrate + Heparin Sodium
1 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| B. Braun Medical Inc. | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- May 9, 2023RECALLRecall (Class II): Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B…
Subpotent: Low anti-factor IIa Potency. — Recalling firm: B. Braun Medical Inc — Nationwide in the USA
- Mar 1, 2023RECALLRecall (Class II): Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.…
Subpotent Drug: low Anti-Factor IIa potency. — Recalling firm: B. Braun Medical Inc — Nationwide in the USA
- Jun 13, 2019RECALLRecall (Class II): Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCEL Container bag,…
Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications. — Recalling firm: B. Braun Medical Inc — Nationwide in the USA